Stem cell therapy is mentioned as a route to stimulate the capacity to regenerate cardiomyocytes in heart failure. In this abstract it is a broad therapeutic category, not a named discrete tool.
First-pass extracted concept
stem cell therapy
Candidate: concept label3 source documents9 linked claims
Live refresh every 5sNext refresh in 5s
Extracted Explainers
Evidence Snippets
to stimulate the capacity to regenerate cardiomyocytes via stem cell therapy have been under intensive research interest
Furthermore, we explore emerging strategies, including gene therapy, stem cell therapy, cell type-specific neuromodulation, and AI-driven techniques for objective, unbiased pain assessment and research.
Current technology iterations, such as gene therapy, stem cell therapy, and optogenetics, are advancing towards precise diagnosis and clinical applications.
Supporting Sources
Linked Claims
The review states that these innovative approaches are poised to enable discovery of safer and more effective analgesics.
Quoted textsource-backed
These innovative approaches are poised to revolutionize pain management, paving the way for the discovery of safer and more effective analgesics.
Opioid-dominated acute pain management is limited by addiction, tolerance, and dependence risks, motivating development of nonopioid analgesics.
Quoted textsource-backed
Acute pain management has historically been dominated by opioids, whose efficacy is overshadowed by the risks of addiction, tolerance, and dependence, culminating in the global opioid crisis. To transcend this issue, we must innovate beyond opioid-based μ receptor treatments, identifying nonopioid analgesics with high efficacy and minimal adverse effects.
Emerging nonopioid pain-management strategies discussed in the review include gene therapy, stem cell therapy, cell type-specific neuromodulation, and AI-driven techniques for objective unbiased pain assessment and research.
Quoted textsource-backed
Furthermore, we explore emerging strategies, including gene therapy, stem cell therapy, cell type-specific neuromodulation, and AI-driven techniques for objective, unbiased pain assessment and research.
Mechanism-based analgesic targets should be tailored to specific pain conditions including inflammatory, neuropathic, and nociplastic pain.
Quoted textsource-backed
This Review navigates the multifaceted landscape of inflammatory, neuropathic, and nociplastic pain, emphasizing mechanism-based analgesic targets tailored to specific pain conditions.
The review presents stem cell therapy as a research direction intended to stimulate cardiomyocyte regeneration in heart failure.
Quoted textsource-backed
to stimulate the capacity to regenerate cardiomyocytes via stem cell therapy have been under intensive research interest
Retinitis pigmentosa is a genetically heterogeneous retinopathy caused by photoreceptor cell death and retinal pigment epithelial atrophy that eventually results in blindness.
Quoted textsource-backed
Retinitis pigmentosa (RP) is genetically heterogeneous retinopathy caused by photoreceptor cell death and retinal pigment epithelial atrophy that eventually results in blindness in bilateral eyes.
Gene therapy, stem cell therapy, and optogenetics are advancing toward precise diagnosis and clinical applications in RP.
Quoted textsource-backed
Current technology iterations, such as gene therapy, stem cell therapy, and optogenetics, are advancing towards precise diagnosis and clinical applications.
Multiple photoreceptor cell death types and pathological phenotypic changes in RP motivate deeper study of pathogenic mechanisms and may contribute to heterogeneous patient responses to mainstream drug treatment.
Quoted textsource-backed
Various photoreceptor cell death types and pathological phenotypic changes that have been disclosed in RP demand in-depth research of its pathogenic mechanism that may account for inter-patient heterogeneous responses to mainstream drug treatment.
Combining conventional therapy with state-of-the-art medication is presented as promising for transforming RP treatment strategies.
Quoted textsource-backed
The combination of conventional therapy and state-of-the-art medication is promising in revolutionizing RP treatment strategies.